Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 3Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 580Neoplasms 487Prostatic Neoplasms 311Lung Neoplasms 238Colorectal Neoplasms 201Motor Activity 131Carcinoma, Non-Small-Cell Lung 117Uterine Cervical Neoplasms 112Brain Neoplasms 110Pancreatic Neoplasms 108Head and Neck Neoplasms 106Stomach Neoplasms 99Carcinoma, Hepatocellular 99Rectal Neoplasms 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 67Multiple Myeloma 65Esophageal Neoplasms 65Hematologic Neoplasms 61Urinary Bladder Neoplasms 60Glioblastoma 59Melanoma 58Sarcoma 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Endometrial Neoplasms 56Glioma 53Lymphoma 50Leukemia, Myeloid, Acute 48Gastrointestinal Neoplasms 48

Interventions

Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Pseudomyxoma Peritonei × Clear all
NCT04024917 2026-01-16

COCOON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
60 enrolled
Gynecologic

Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT07328737 2026-01-09

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Beijing Tsinghua Chang Gung Hospital

Phase NA Recruiting
132 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡